A 7-year-old gelding American Quarter Horse used for reining, barrel racing, and extreme trail riding presented with a stifle injury sustained during a sliding stop at an event. The injury occurred approximately two months prior to treatment. Despite initial management with rest and anti-inflammatory therapy, the horse continued to show a persistent 2/5 lameness and was not tracking up correctly in the hind limbs.
The patient was treated with VetREnew stem cell therapy. A total of 2 mL of stem cells was administered intra-articularly into both stifle joints and the left hock. The horse was then placed on box rest and gradually reintroduced to controlled work.
Twelve weeks post-treatment, the horse exhibited marked clinical improvement. He began tracking up evenly, was able to cross over during spins—previously impaired—and consistently picked up the correct lead at the canter. No adverse effects were observed during or after the procedure.
This case highlights the potential value of VetREnew stem cell therapy in resolving persistent lameness and enhancing functional performance in high-demand equine athletes with joint-related injuries.
— Dr. Carly Barkley
